← Eichor
Study identifier: NCT04302025 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

Condition: Non-small Cell Lung Cancer  ·  Sponsor: Genentech, Inc.

PhasePhase 2
Planned participants99
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This trial will evaluate the efficacy and safety of various therapies in participants with Stage IB, IIA, IIB, IIIA, or selected IIIB resectable and untreated NSCLC tumors that meet protocol-specified biomarker criteria.

This description comes directly from the study's public registry record.

Talk to the study team

Reference Study ID Number: ML41591 https://forpatients.roche.com/  ·  888-662-6728  ·  global-roche-genentech-trials@gene.com

Fastest response: use the inquiry form. No email attachments. https://www.gene.com/contact-us/submit-medical-inquiry

Always discuss trial participation with your own doctor first.

Locations (38)

City of Hope Comprehensive Cancer CenterDuarte, California, United StatesWithdrawn
City of Hope - Orange County Lennar Foundation Cancer CenterIrvine, California, United StatesWithdrawn
USC Norris Cancer CenterLos Angeles, California, United StatesWithdrawn
Cedars-Sinai Medical CenterLos Angeles, California, United StatesWithdrawn
University of California Los Angeles - Jonsson Comprehensive Cancer CenterLos Angeles, California, United StatesRecruiting
The Center for Cancer Prevention and Treatment at St.Joseph Hospital of OrangeOrange, California, United StatesRecruiting
UC Davis Comprehensive Cancer CenterSacramento, California, United StatesRecruiting
UCSF Helen Diller Family CCCSan Francisco, California, United StatesWithdrawn
University of Colorado - Anschutz Medical Campus (University of Colorado Health Sciences Center)Aurora, Colorado, United StatesWithdrawn
Yale Cancer CenterNew Haven, Connecticut, United StatesRecruiting
MedStar Georgetown University Hospital (Lombardi Comprehensive Cancer Center)Washington D.C., District of Columbia, United StatesRecruiting
Moffitt Cancer CenterTampa, Florida, United StatesRecruiting

+ 26 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04302025